Evidence map›Paper›PMID 40416488›Full record

ArticleJournal of the ASEAN Federation of Endocrine Societies2025

A Tumultuous Journey of Metastatic Pancreatic Neuroendocrine Tumor with Carcinoid Syndrome.

Somdatta Giri, Sadishkumar Kamalanathan, Kalayarasan Raja, Nandini Pandit, Dukhabandhu Naik, Jayaprakash Sahoo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the ASEAN Federation of Endocrine Societies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Somdatta GiriDepartment of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Sadishkumar KamalanathanDepartment of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Kalayarasan RajaDepartment of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Nandini PanditDepartment of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Dukhabandhu NaikDepartment of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Jayaprakash SahooDepartment of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 25-year-old woman presented with metastatic pancreatic neuroendocrine tumor with carcinoid syndrome. She was refractory to octreotide and did not respond well to chemotherapy. Although surgical debulking remains the primary approach for managing these tumours, it entails inherent risks, including potentially exacerbating carcinoid syndrome. We strategically delivered the one Peptide Receptor Radionuclide Therapy cycle before tumor debulking, a decision that yielded a remarkable response, stabilizing her condition.

Indexed as

Malignant Carcinoid SyndromeNeuroendocrine TumorsPancreatic NeoplasmsAdultFemaleHumansOctreotideOctreotidemetastaticnorepinephrineoctreotide refractorypancreatic neuroendocrine tumorpeptide receptor radionuclide therapy

Identifiers

PMID40416488
PMCPMC12102652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.